Latest Breaking News On - Steele laboratories - Page 1 : comparemela.com

Antihypertension drug may benefit patients with neurofibromatosis type 2 New research led by investigators at Massachusetts General Hospital (MGH) and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2), a hereditary condition associated with vestibular schwannomas, or noncancerous tumors along the nerves in the brain that are involved with hearing and balance. The findings, which are published in Science Translational Medicine, are especially important because vestibular schwannomas are currently treated with surgery and radiation therapy (which carry risks of nerve damage), and no drug is approved by the U.S. Food and Drug Administration to treat these tumors or their associated hearing loss.

United statesKonstantina stankovicEmily hendersonDepartment of otolaryngologyDrug administrationDepartment of radiation oncologyDivision of otologyMassachusetts general hospitalMassachusetts eyeScience translational medicineSteele laboratoriesTumor biologyBertarelli professorNeck surgeryStanford university schoolஒன்றுபட்டது மாநிலங்களில்